Skip to main content

Table 1 Baseline characteristics of included patients

From: Effectiveness and safety of artemether–lumefantrine versus artesunate–amodiaquine for unsupervised treatment of uncomplicated falciparum malaria in patients of all age groups in Nanoro, Burkina Faso: a randomized open label trial

Characteristics AL, n = 340 (%) ASAQ, n = 340 (%) P-value
Site
 Nanoro, n (%) 176 (51.76) 176 (51.76)
 Nazoanga, n (%) 164 (48.24) 164 (48.24)
Sex
 Male, n (%) 183 (53.82) 182 (53.53) 0.939
 Female, n (%) 157 (46.18) 158 (46.47)
Age in years, median (p25–p75) 3.26 (1.70–4.98) 3.14 (1.61–5.05) 0.387
Weight in kg, median (p25–p75) 11 (9–14) 10 (9–14) 0.157
Mean temperature (SD) 38.41 (0.91) 38.47 (0.91) 0.381
Hemoglobin in g/dl, median (p25–p75) 9 (8–11) 9 (8–10) 0.019
GMPD (95 % CI) 30,529 (26,809–34,766) 30,763 (27,180–34,818) 0.933